Senzime, a medical device company specializing in precision neuromuscular monitoring, reported a 14% revenue growth in Q3 2026. The company’s disposable sensor sales surged by 43%, driving recurring revenue from its TetraGraph system used in operating rooms worldwide. With about 6,000 systems delivered and over 1.3 million patients monitored, Senzime continues to expand its presence in 30 markets and 800 hospitals. The strong growth reflects recovery post-COVID and highlights the company’s innovation and patent portfolio supporting its technology.
Senzime AB's Q3 2026 earnings call highlights a 14% revenue growth, supported by a 43% surge in disposable sensor sales. For readers following the health sector, here is Pluang's market snapshot as of Oct 29, 2026 18:11 WIB: out of 150 priced US health stocks, 95 rose and 47 fell. Notable movers include Inovio Pharmaceuticals Inc (INO) at USD 0.96 with a 3.38% gain and a typical hold time of 43 days, Novartis AG (NVS) at USD 160.96 up 3.13% with an 84-day hold, and Sana Biotechnology Inc (SANA) at USD 2.71 rising 3.04% but with 96% sell order activity.
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...
Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...
Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...
